AU2005229359C1 - Process for cell culturing by continuous perfusion and alternating tangential flow - Google Patents

Process for cell culturing by continuous perfusion and alternating tangential flow Download PDF

Info

Publication number
AU2005229359C1
AU2005229359C1 AU2005229359A AU2005229359A AU2005229359C1 AU 2005229359 C1 AU2005229359 C1 AU 2005229359C1 AU 2005229359 A AU2005229359 A AU 2005229359A AU 2005229359 A AU2005229359 A AU 2005229359A AU 2005229359 C1 AU2005229359 C1 AU 2005229359C1
Authority
AU
Australia
Prior art keywords
cells
cell
culture
perfusion
per
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2005229359A
Other languages
English (en)
Other versions
AU2005229359A1 (en
AU2005229359B2 (en
Inventor
Jose Manuel Coco Martin
John Crowley
Maike Wubben
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Patheon Holdings I BV
Original Assignee
Patheon Holdings I BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34961830&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2005229359(C1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Patheon Holdings I BV filed Critical Patheon Holdings I BV
Publication of AU2005229359A1 publication Critical patent/AU2005229359A1/en
Application granted granted Critical
Publication of AU2005229359B2 publication Critical patent/AU2005229359B2/en
Publication of AU2005229359C1 publication Critical patent/AU2005229359C1/en
Priority to AU2013203461A priority Critical patent/AU2013203461B2/en
Priority to AU2013203993A priority patent/AU2013203993C1/en
Priority to AU2013203995A priority patent/AU2013203995B2/en
Assigned to DPX HOLDINGS B.V. reassignment DPX HOLDINGS B.V. Request for Assignment Assignors: DSM IP ASSETS B.V.
Assigned to PATHEON HOLDINGS I B.V. reassignment PATHEON HOLDINGS I B.V. Request to Amend Deed and Register Assignors: DPX HOLDINGS B.V.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M3/00—Tissue, human, animal or plant cell, or virus culture apparatus
    • C12M3/06—Tissue, human, animal or plant cell, or virus culture apparatus with filtration, ultrafiltration, inverse osmosis or dialysis means
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
    • C12M25/10—Hollow fibers or tubes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/10—Perfusion
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/44—Means for regulation, monitoring, measurement or control, e.g. flow regulation of volume or liquid level
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2521/00—Culture process characterised by the use of hydrostatic pressure, flow or shear forces

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Sustainable Development (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Botany (AREA)
  • Water Supply & Treatment (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AU2005229359A 2004-03-05 2005-03-04 Process for cell culturing by continuous perfusion and alternating tangential flow Ceased AU2005229359C1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2013203461A AU2013203461B2 (en) 2004-03-05 2013-04-10 Process for cell culturing by continuous perfusion and alternating tangential flow
AU2013203993A AU2013203993C1 (en) 2004-03-05 2013-04-11 Process for cell culturing by continuous perfusion and alternating tangential flow
AU2013203995A AU2013203995B2 (en) 2004-03-05 2013-04-11 Process for cell culturing by continuous perfusion and alternating tangential flow

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
EP04075702.3 2004-03-05
EP04075703.1 2004-03-05
EP04075702 2004-03-05
EP04075703 2004-03-05
EP04077656.9 2004-09-27
EP04077657 2004-09-27
EP04077656 2004-09-27
EP04077657.7 2004-09-27
PCT/EP2005/002374 WO2005095578A1 (en) 2004-03-05 2005-03-04 Process for cell culturing by continuous perfusion and alternating tangential flow

Related Child Applications (3)

Application Number Title Priority Date Filing Date
AU2013203461A Division AU2013203461B2 (en) 2004-03-05 2013-04-10 Process for cell culturing by continuous perfusion and alternating tangential flow
AU2013203993A Division AU2013203993C1 (en) 2004-03-05 2013-04-11 Process for cell culturing by continuous perfusion and alternating tangential flow
AU2013203995A Division AU2013203995B2 (en) 2004-03-05 2013-04-11 Process for cell culturing by continuous perfusion and alternating tangential flow

Publications (3)

Publication Number Publication Date
AU2005229359A1 AU2005229359A1 (en) 2005-10-13
AU2005229359B2 AU2005229359B2 (en) 2009-01-08
AU2005229359C1 true AU2005229359C1 (en) 2011-07-28

Family

ID=34961830

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005229359A Ceased AU2005229359C1 (en) 2004-03-05 2005-03-04 Process for cell culturing by continuous perfusion and alternating tangential flow

Country Status (14)

Country Link
US (3) US8206981B2 (enExample)
EP (3) EP2540815A1 (enExample)
JP (6) JP2007525984A (enExample)
KR (1) KR101050585B1 (enExample)
CN (3) CN104388324A (enExample)
AU (1) AU2005229359C1 (enExample)
CA (1) CA2557046A1 (enExample)
DK (1) DK1720972T3 (enExample)
ES (1) ES2456015T3 (enExample)
IL (2) IL177724A (enExample)
PL (1) PL1720972T3 (enExample)
PT (1) PT1720972E (enExample)
SI (1) SI1720972T1 (enExample)
WO (1) WO2005095578A1 (enExample)

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104388324A (zh) 2004-03-05 2015-03-04 帝斯曼知识产权资产管理有限公司 用于通过连续灌注和交互切向流来培养细胞的方法
BRPI0707027B1 (pt) 2006-02-24 2022-08-16 Toray Industries, Inc Método de fabricação de um produto químico e aparelho de fermentação contínua
EP1870450A1 (en) * 2006-06-21 2007-12-26 DSMIP Assets B.V. Process for the culturing of E1-immortalized HER cells
AU2011211462C1 (en) * 2006-07-14 2015-01-22 Dpx Holdings B.V. Improved process for the culturing of cells
DK2634242T3 (en) 2006-07-14 2017-05-22 Patheon Holdings I B V IMPROVED PROCEDURE FOR CULTURING CELLS
EP2014760A1 (en) 2007-06-13 2009-01-14 CMC Biopharmaceuticals A/S A method for producing a biopolymer (e.g. polypeptide) in a continuous fermentation process
AU2008345231B2 (en) * 2007-12-27 2014-09-11 Takeda Pharmaceutical Company Limited Cell culture processes
WO2010003759A2 (en) * 2008-06-17 2010-01-14 Dsm Ip Assets B.V. Cell culturing method
MX2011002328A (es) * 2008-09-02 2011-05-19 Pluristem Ltd Celulas adherentes del tejido de placenta y su uso en terapia.
WO2010060719A1 (en) * 2008-11-03 2010-06-03 Crucell Holland B.V. Method for the production of adenoviral vectors
PE20120571A1 (es) 2009-07-16 2012-06-06 Crucell Holland Bv Produccion de titulos elevados de polivirus para la produccion de vacunas
CN102791852B (zh) 2009-10-15 2014-05-07 克鲁塞尔荷兰公司 纯化腺病毒颗粒的方法
KR101805938B1 (ko) 2009-10-15 2018-01-10 얀센 백신스 앤드 프리벤션 비.브이. 고밀도 세포 배양액에서 아데노바이러스의 정제 방법
SMT201700529T1 (it) 2009-11-17 2018-01-11 Squibb & Sons Llc Metodi per un'aumentata produzione di proteine
EP2536829B1 (en) * 2010-02-15 2016-04-06 Crucell Holland B.V. Method for the production of Ad26 adenoviral vectors
US20120315696A1 (en) * 2010-02-15 2012-12-13 Alfred Luitjens METHOD FOR THE PRODUCTION OF Ad26 ADENOVIRAL VECTORS
WO2011144561A1 (en) 2010-05-18 2011-11-24 Crucell Holland B.V. Methods for welding ethylene vinyl acetate (eva) tubing, tubing obtained thereby and use of such tubing for sterile transfer of content into a bioreactor
EP2957628A1 (en) * 2010-10-05 2015-12-23 Novo Nordisk Health Care AG Process for protein production
US9115381B2 (en) * 2011-05-13 2015-08-25 Octapharma Ag Method of increasing the productivity of eucaryotic cells in the production of recombinant FVIII
CA2838695C (en) * 2011-07-01 2017-02-14 Amgen Inc. Mammalian cell culture
CN104011073B (zh) 2011-10-18 2017-08-25 科荣生生物科学公司 使用氨基酸稳定的依那西普制剂
US10493151B2 (en) 2011-10-18 2019-12-03 Coherus Biosciences, Inc. Etanercept formulations stabilized with sodium chloride
CN103305417A (zh) * 2012-03-07 2013-09-18 无锡药明康德生物技术有限公司 进行蛋白生产的高产量反应器及其生产方法和应用
GB201211256D0 (en) 2012-06-25 2012-08-08 Glaxosmithkline Biolog Sa Fermentation process
EP2869816A4 (en) 2012-07-09 2016-04-20 Coherus Biosciences Inc ETANERCEPT FORMULATIONS WITH CLEAR REDUCTION OF SUBVISIBLE PARTICLES
RS57013B1 (sr) 2012-09-11 2018-05-31 Coherus Biosciences Inc Korektno savijeni etanercept sa visokom čistoćom i odličnim prinosom
JP6321661B2 (ja) * 2012-09-27 2018-05-09 ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ タンジェンシャルフロー灌流システム及び方法
TWI637057B (zh) 2012-11-09 2018-10-01 拜爾沙納有限公司 具交替生物反應器用途之不連續進料批次製程
EP4008768A1 (en) * 2013-03-15 2022-06-08 Genzyme Corporation High-density cell banking methods
DK2976418T3 (da) 2013-03-19 2021-01-11 Cmc Biologics As Fremgangsmåde til fremstilling af et produkt (f.eks. polypeptid) i en kontinuerlig cellekulturfermenteringsproces
MX362922B (es) * 2013-03-26 2019-02-25 Coherus Biosciences Inc Método de producción de proteínas.
US9790465B2 (en) 2013-04-30 2017-10-17 Corning Incorporated Spheroid cell culture well article and methods thereof
KR102749545B1 (ko) * 2013-09-16 2025-01-07 젠자임 코포레이션 세포 배양물을 가공하는 방법 및 시스템
CN105579572B (zh) 2013-09-30 2018-08-10 扬森疫苗与预防公司 用于净化高密度粗细胞培养收获物的方法
CN103525756B (zh) * 2013-10-23 2015-04-08 南京农业大学 一种原代鸡肝细胞的分离培养方法
US20160289633A1 (en) * 2013-12-20 2016-10-06 Biogen Ma Inc. Use of Perfusion Seed Cultures to Improve Biopharmaceutical Fed-Batch Production Capacity and Product Quality
KR102410393B1 (ko) * 2014-01-29 2022-06-16 암젠 인크 재조합 단백질의 글리코실화를 조절하기 위한 n-글리코실화 경로 조절자의 과발현
US20170009269A1 (en) * 2014-02-17 2017-01-12 Advantech Bioscience Farmacêutica Ltda Enhancement of recombinant protein expression using a membrane-based cell retention system
CN106687575B (zh) 2014-06-04 2021-04-30 美国安进公司 用于收获哺乳动物细胞培养物的方法
EP3172317B1 (en) 2014-07-24 2019-05-01 Janssen Vaccines & Prevention B.V. Process for the purification of poliovirus from cell cultures
JP6530171B2 (ja) * 2014-09-09 2019-06-12 旭化成メディカル株式会社 培養産生物の回収方法
MX383858B (es) * 2014-09-18 2025-03-14 Genzyme Corp Métodos de establecimiento de bancos de células de densidad ultra-alta.
CN107109339B (zh) 2014-10-29 2021-07-02 康宁股份有限公司 灌注生物反应器平台
EP3212761A1 (en) 2014-10-29 2017-09-06 Corning Incorporated Microwell design and fabrication for generation of cell culture aggregates
SG11201703493SA (en) 2014-10-29 2017-05-30 Corning Inc Cell culture insert
WO2016073858A1 (en) 2014-11-07 2016-05-12 Genesis Technologies, Llc Linear reciprocating actuator
MX383857B (es) 2014-12-22 2025-03-14 Genzyme Corp Métodos de cultivo de una célula de mamífero.
EP3256565A1 (en) * 2015-02-09 2017-12-20 Univercells NV System, apparatus and method for the production of cells and/or cell products
CA3018264A1 (en) 2016-04-12 2017-10-19 Artemis Biosystems, Inc. Perfusion filtration systems
ES3054035T3 (en) 2016-04-14 2026-01-28 Ferring Ventures Ltd Fixed-bed bioreactor with constant-flow pump/tubing system
EP3722436B1 (en) 2016-04-14 2025-09-24 Ferring Ventures Ltd Fixed-bed bioreactor with constant-flow pump/tubing system
US12157877B2 (en) 2016-04-15 2024-12-03 Boehringer Ingelheim International Gmbh Cell retention device and method
EP3480293A4 (en) * 2016-06-30 2019-07-03 FUJIFILM Corporation Cell suspension membrane separation device and cell culture device
IL291373B2 (en) * 2016-07-11 2023-10-01 Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd Methods and systems for growing cells in culture
JP7195302B2 (ja) 2017-07-14 2022-12-23 コーニング インコーポレイテッド ３ｄ培養のための細胞培養容器及び３ｄ細胞の培養方法
US11767499B2 (en) 2017-07-14 2023-09-26 Corning Incorporated Cell culture vessel
PL3652290T3 (pl) 2017-07-14 2022-08-22 Corning Incorporated Naczynia do hodowli komórkowej 3d do ręcznej lub automatycznej zmiany pożywek
US11857970B2 (en) 2017-07-14 2024-01-02 Corning Incorporated Cell culture vessel
CN111051496B (zh) * 2017-09-06 2024-03-08 富士胶片株式会社 产物的制造方法
WO2019055796A1 (en) * 2017-09-15 2019-03-21 Bristol-Myers Squibb Company ONLINE BIOMASS CAPACITY MONITORING DURING LARGE SCALE PRODUCTION OF POLYPEPTIDES OF INTEREST
IL273549B2 (en) 2017-10-06 2023-10-01 Lonza Ag Automated control of cell culture using Raman spectroscopy
TW202538049A (zh) 2017-10-16 2025-10-01 美商再生元醫藥公司 灌注生物反應器及相關使用方法
TWI827570B (zh) * 2017-12-11 2024-01-01 美商安進公司 雙特異性抗體產品之連續製造製程
AU2019231885B2 (en) * 2018-03-08 2022-03-24 Repligen Corporation Tangential flow depth filtration systems and methods of filtration using same
CN110241012B (zh) * 2018-03-09 2022-11-01 嘉和生物药业有限公司 一种生物大分子上游分阶段截留的生产方法、生产模块及在生产中的应用
EP3770266A4 (en) * 2018-03-19 2021-06-09 FUJIFILM Corporation PRODUCT MANUFACTURING PROCESS
US11958018B2 (en) 2018-05-25 2024-04-16 Repligen Corporation Tangential flow filtration systems and methods
CN108504562A (zh) * 2018-06-21 2018-09-07 江苏澳创生物科技有限公司 一种发酵生产l-苏氨酸的系统及其应用
CN111065725B (zh) 2018-07-13 2024-03-29 康宁股份有限公司 包括具有互联的壁的微板的流体装置
WO2020013845A1 (en) 2018-07-13 2020-01-16 Corning Incorporated Cell culture vessels with stabilizer devices
US11912968B2 (en) 2018-07-13 2024-02-27 Corning Incorporated Microcavity dishes with sidewall including liquid medium delivery surface
US12478571B2 (en) 2018-12-17 2025-11-25 Pontis Biologics, Inc. Enzyme based compositions and methods for removing dental calculi
WO2020165873A1 (en) * 2019-02-15 2020-08-20 Oncosimis Biotech Private Limited Method and system for enhanced continuous production, secretion and separation of recombinant polypeptides from bacteria
US20220243225A1 (en) * 2019-04-29 2022-08-04 Voyager Therapeutics, Inc. SYSTEMS AND METHODS FOR PRODUCING BACULOVIRAL INFECTED INSECT CELLS (BIICs) IN BIOREACTORS
EP3983520A1 (en) * 2019-06-13 2022-04-20 Amgen, Inc Automated biomass-based perfusion control in the manufacturing of biologics
WO2021008571A1 (zh) * 2019-07-16 2021-01-21 信达生物制药(苏州)有限公司 高密度连续接种的细胞培养方法及其应用
JP2023503849A (ja) * 2019-11-15 2023-02-01 ロンザ リミテッド 接種物を生産するためのプロセスおよびシステム
CA3189533A1 (en) 2020-07-28 2022-02-03 Seagen Inc. Methods and systems for producing polypeptides
JP2023546736A (ja) * 2020-10-15 2023-11-07 エージーシー バイオロジクス，インコーポレーテッド 二重容器接線流濾過による連続的高細胞密度培養
MX2023012193A (es) * 2021-04-14 2023-10-25 Genzyme Corp Metodos de cultivo de perfusion de una celula de mamifero.
CA3266599A1 (en) 2022-09-07 2024-11-07 Quantitative Biosciences, Inc. UNIQUE VARIABLE DOMAIN ANTIBODIES SPECIFIC TO FENTANYL AND USE IN A CONTINUOUS AGGLUTINATION TEST
CN116179464A (zh) * 2022-12-06 2023-05-30 无锡药明生物技术股份有限公司 提高培养液细胞密度和高密度细胞培养的方法
AU2024235963A1 (en) * 2023-03-14 2025-08-07 Sonnet BioTherapeutics, Inc. Methods of making recombinant il-12 albumin binding domain fusion proteins
WO2024192116A1 (en) * 2023-03-14 2024-09-19 Repligen Corporation High viable cell density transfection
EP4702164A1 (en) 2023-04-24 2026-03-04 Quantitative Biosciences, Inc. Engineered biosensor strains of e. coli for continuous aerobic detection of analytes
CN121175432A (zh) * 2023-05-31 2025-12-19 富士胶片株式会社 生产物的生产方法
WO2025128343A1 (en) 2023-12-11 2025-06-19 Just-Evotec Biologics, Inc. Protein expression using trans-splicing and split selectable markers
EP4711442A1 (en) 2024-09-15 2026-03-18 Quantitative Biosciences, Inc. Microfluidic chip for the parallel culture of microbial biosensor strains

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544424B1 (en) * 1999-12-03 2003-04-08 Refined Technology Company Fluid filtration system

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US54544A (en) * 1866-05-08 Improvement in low-water detecters
JPS61199788A (ja) 1985-02-28 1986-09-04 Mitsubishi Rayon Co Ltd 醗酵生成物の分離濃縮方法及び連続醗酵方法
US5286646A (en) 1985-11-25 1994-02-15 Boehringer Mannheim Gmbh Method for mammalian cell culture
GB8617646D0 (en) 1986-07-18 1986-08-28 Manchester Inst Science Tech Recovery of biological material
US4806484A (en) 1987-08-07 1989-02-21 Igb Products, Ltd. Perfusion airlift bioreactor
JPH0797982B2 (ja) 1987-09-24 1995-10-25 東洋紡績株式会社 細胞培養装置
US4921792A (en) 1987-11-27 1990-05-01 Miles Inc. Continuous cell dispersion, cultivation and substance recovery process
JPH01243985A (ja) 1988-03-25 1989-09-28 P C C Technol:Kk 植物器官の培養法及びその培養槽
US5595909A (en) * 1988-05-23 1997-01-21 Regents Of The University Of Minnesota Filter device
DE68917642T2 (de) 1988-05-25 1995-02-09 Teijin Ltd Verfahren zur kontinuierlichen Züchtung von haftenden tierischen Zellen.
JPH02113896A (ja) * 1988-10-24 1990-04-26 Snow Brand Milk Prod Co Ltd ヒト抗リシンモノクローナル抗体およびそれを分泌するハイブリドーマ
US5019512A (en) * 1989-03-17 1991-05-28 Baxter International Inc. Spin filter for removing substantially cell-free culture medium from suspension cell culture system
JPH0541984A (ja) * 1990-09-07 1993-02-23 Dow Chem Co:The 攪拌容器における中空繊維においての細胞の増殖
US5256294A (en) 1990-09-17 1993-10-26 Genentech, Inc. Tangential flow filtration process and apparatus
GB9118664D0 (en) 1991-08-30 1991-10-16 Celltech Ltd Cell culture
JPH05153973A (ja) 1991-12-03 1993-06-22 Hitachi Ltd 細胞培養方法及び装置
US6204000B1 (en) 1995-04-28 2001-03-20 The United States Of America As Represented By The Department Of Health And Human Services Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1
JP2752918B2 (ja) * 1995-05-16 1998-05-18 ユーエイチティー株式会社 動物細胞のマイクロキャリア培養法
US6001585A (en) 1997-11-14 1999-12-14 Cellex Biosciences, Inc. Micro hollow fiber bioreactor
JP2997771B2 (ja) * 1998-06-29 2000-01-11 金沢大学長 細胞の懸濁培養方法
US8026096B1 (en) 1998-10-08 2011-09-27 Protein Sciences Corporation In vivo active erythropoietin produced in insect cells
US6103526A (en) 1998-10-08 2000-08-15 Protein Sciences Corporation Spodoptera frugiperda single cell suspension cell line in serum-free media, methods of producing and using
US6667176B1 (en) 2000-01-11 2003-12-23 Geron Corporation cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
CA2252972C (en) 1998-11-26 2012-09-18 National Research Council Of Canada Serum-free production of recombinant proteins and adenoviral vectors
WO2000044883A1 (en) * 1999-01-26 2000-08-03 Schering-Plough Ltd. Propagation of bovine coronavirus in chinese hamster ovary cells
ES2237420T5 (es) * 1999-04-15 2010-03-03 Crucell Holland B.V. Produccion de proteina recombinante en una celula humana.
US6855544B1 (en) * 1999-04-15 2005-02-15 Crucell Holland B.V. Recombinant protein production in a human cell
EP1103610A1 (en) * 1999-11-26 2001-05-30 Introgene B.V. Production of vaccines from immortalised mammalian cell lines
JP2001149099A (ja) 1999-11-26 2001-06-05 Olympus Optical Co Ltd 染色体異常解析のための有核細胞の標本作製方法
US6168941B1 (en) * 2000-04-07 2001-01-02 Genvec, Inc. Method of producing adenoviral vector stocks
JP4138209B2 (ja) 2000-06-29 2008-08-27 エーザイ・アール・アンド・ディー・マネジメント株式会社 プラバスタチン含有組成物
JP2002113896A (ja) 2000-10-05 2002-04-16 Seiko Epson Corp 画像形成装置
ATE422216T1 (de) * 2001-04-17 2009-02-15 Seiren Kabushiki Kaisha Mediumzusätze und medien für tierzellkulturen
DE10120835C2 (de) 2001-04-27 2003-04-10 Sifin Inst Fuer Immunpraeparat Verfahren zur Herstellung von monoklonalen Antikörpern
CA2351156A1 (en) 2001-07-04 2003-01-04 Peter W. Zandstra A bioprocess for the generation of pluripotent cell derived cells and tissues
KR100909316B1 (ko) * 2001-08-31 2009-07-24 바이엘 헬스케어 아게 고세포밀도 발효를 수행하기 위한 유닛 및 방법
MXPA04002099A (es) 2001-09-05 2004-06-07 Yamasa Corp Composiciones medicinales para neuropatia diabetica.
WO2003025158A1 (en) 2001-09-14 2003-03-27 Medcell Biologics, Inc. Oxygen enriched bioreactor and method of culturing cells
JP2003219873A (ja) 2002-01-24 2003-08-05 Japan Science & Technology Corp サケ科キングサーモン由来の不死化細胞
US20030186335A1 (en) 2002-03-28 2003-10-02 National Institute Of Advanced Industrial Science And Technology Monoclonal antibodies, hybridomas, cell isolation method, isolated cells and immunological diagnostic method
DE10237082B4 (de) * 2002-08-09 2014-12-31 Sartorius Stedim Biotech Gmbh Verfahren und Vorrichtung zur biotechnologischen Herstellung von Wertstoffen
CN100383238C (zh) 2003-05-09 2008-04-23 克鲁塞尔荷兰公司 E1-永生化的细胞培养物及培养所述细胞以提高从中获取的产物产量的方法
JP2005041984A (ja) 2003-07-22 2005-02-17 Shin Kobe Electric Mach Co Ltd 水架橋ポリオレフィン製シートの製造法
CN104388324A (zh) 2004-03-05 2015-03-04 帝斯曼知识产权资产管理有限公司 用于通过连续灌注和交互切向流来培养细胞的方法
DK2634242T3 (en) * 2006-07-14 2017-05-22 Patheon Holdings I B V IMPROVED PROCEDURE FOR CULTURING CELLS
JP2008308560A (ja) 2007-06-13 2008-12-25 Tohcello Co Ltd 表面防汚性複合フィルムの製造方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544424B1 (en) * 1999-12-03 2003-04-08 Refined Technology Company Fluid filtration system

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BANIK and HEATH; Biotech nol Prog (1995), Vol 11 pp 548-588 *
FUREY et al, Genetic Engg News (2000) Vol 20, no 10, pp 52-53 *

Also Published As

Publication number Publication date
SI1720972T1 (sl) 2014-06-30
JP2011125348A (ja) 2011-06-30
DK1720972T3 (da) 2014-04-14
WO2005095578A1 (en) 2005-10-13
AU2005229359A1 (en) 2005-10-13
JP2007525984A (ja) 2007-09-13
JP2012090632A (ja) 2012-05-17
PL1720972T3 (pl) 2014-06-30
EP2308958A2 (en) 2011-04-13
US20130266985A1 (en) 2013-10-10
JP5719947B2 (ja) 2015-05-20
IL177724A (en) 2011-01-31
EP2308958A3 (en) 2011-08-10
IL177724A0 (en) 2006-12-31
KR101050585B1 (ko) 2011-07-19
ES2456015T3 (es) 2014-04-21
CA2557046A1 (en) 2005-10-13
CN104593277A (zh) 2015-05-06
IL205606A (en) 2011-08-31
JP2014128272A (ja) 2014-07-10
US9260695B2 (en) 2016-02-16
AU2005229359B2 (en) 2009-01-08
CN1930281A (zh) 2007-03-14
CN104388324A (zh) 2015-03-04
EP1720972B1 (en) 2014-01-08
JP2016039817A (ja) 2016-03-24
EP2540815A1 (en) 2013-01-02
EP1720972A1 (en) 2006-11-15
US20080131934A1 (en) 2008-06-05
US20140087424A1 (en) 2014-03-27
PT1720972E (pt) 2014-04-07
JP2017225443A (ja) 2017-12-28
US8206981B2 (en) 2012-06-26
KR20070022221A (ko) 2007-02-26

Similar Documents

Publication Publication Date Title
AU2005229359C1 (en) Process for cell culturing by continuous perfusion and alternating tangential flow
US9670520B2 (en) Process for the culturing of cells
AU2013203993C1 (en) Process for cell culturing by continuous perfusion and alternating tangential flow
DK2226381T3 (en) Process for the cultivation of cells for production of compounds
HK1179646A (en) Perfusion cell culture
HK1104189A (en) Process for cell culturing by continuous perfusion and alternating tangential flow

Legal Events

Date Code Title Description
CB Opposition filed

Opponent name: REFINE TECHNOLOGY, LLC

DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 29 NOV 2010.

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 29 NOV 2010

PC1 Assignment before grant (sect. 113)

Owner name: DPX HOLDINGS B.V.

Free format text: FORMER APPLICANT(S): DSM IP ASSETS B.V.

DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 28 NOV 2014 .

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 28 NOV 2014

FGA Letters patent sealed or granted (standard patent)
HB Alteration of name in register

Owner name: PATHEON HOLDINGS I B.V.

Free format text: FORMER NAME(S): DPX HOLDINGS B.V.

MK14 Patent ceased section 143(a) (annual fees not paid) or expired